New GLP Data for Sleep Apnea and Weight Loss

CEimpact Podcast

GLP1 usage is on the rise. This week on GameChangers, we discuss the latest data on using GLP-1s for sleep apnea and weight loss.
The GameChanger
Several new studies suggest GLP-1 and GLP/GIP medications have positive clinical impact on sleep apnea and weight loss.
Guests
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad
References
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity

Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the use of GLP-1 medications in the treatment of obstructive sleep apnea.
2. Discuss the relative weight loss in a recent study between a GLP-1 and GLP/GIP drugs.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-238-H01-P
Initial release date: 07/29/2024
Expiration date: 07/29/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Chapters

1. GLP-1s and Sleep Apnea Research (00:00:00)

2. Terspatide and Sleep Apnea Treatment (00:07:39)

3. Sleep Apnea Drug Availability and Cost (00:15:19)

4. Comparing Trusepatide and Semiglutide Weight Loss (00:24:43)

5. Obesity Treatment Options and Concerns (00:35:10)